<生产厂家价格>

4-硝基苯基-α-D-吡喃甘露糖苷

4-硝基苯基-α-D-吡喃甘露糖苷用途

对硝基苯基α-D-甘露糖糖苷是一种生物化学试剂,可作为生物材料或有机化合物进行生命科学相关研究。

4-硝基苯基-α-D-吡喃甘露糖苷名称

[ CAS 号 ]:
10357-27-4

[ 中文名 ]:
对硝基苯-Alpha-D-吡喃甘露糖苷

[ 英文名 ]:
4-Nitrophenyl α-D-mannopyranoside

[中文别名 ]:

[英文别名 ]:

MFCD00066002
p-nitrophenyl mannoside
4-Nitrophenyl α-D-mannopyranoside
4-NITROPHENYL-A-D-MANNOSIDE
EINECS 233-776-6
MAN1-A-PNP
α-D-Mannopyranoside, 4-nitrophenyl
p-Nitrophenyl Alpha-D-Mannopyranoside
4-Nitrophenyl α-D-Mannopyranoside [Substrate
4-Nitrophenyla-D-mannopyranoside

4-硝基苯基-α-D-吡喃甘露糖苷生物活性

[ 描述 ]:

对硝基苯基α-D-甘露糖糖苷是一种生物化学试剂,可作为生物材料或有机化合物进行生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

4-硝基苯基-α-D-吡喃甘露糖苷物理化学性质

[ 密度 ]:
1.6±0.1 g/cm3

[ 沸点 ]:
582.2±50.0 °C at 760 mmHg

[ 熔点 ]:
179-181ºC

[ 分子式 ]:
C₁₂H₁₅NO₈

[ 分子量 ]:
301.249

[ 闪点 ]:
305.9±30.1 °C

[ 精确质量 ]:
301.079773

[ PSA ]:
145.20000

[ LogP ]:
-0.55

[ 外观性状 ]:
白色-黄色晶体粉末

[ 蒸汽压 ]:
0.0±1.7 mmHg at 25°C

[ 折射率 ]:
1.648

[ 储存条件 ]:
2-8°C

[ 水溶解性 ]:
DMF: 50 mg/mL, clear, very faintly yellow

4-硝基苯基-α-D-吡喃甘露糖苷MSDS

4-硝基苯基-α-D-吡喃甘露糖苷安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
24/25-36-26

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2932999099

4-硝基苯基-α-D-吡喃甘露糖苷合成路线

4-硝基苯基-α-D-吡喃甘露糖苷上下游产品

4-硝基苯基-α-D-吡喃甘露糖苷上游产品

4-硝基苯基-α-D-吡喃甘露糖苷下游产品

4-硝基苯基-α-D-吡喃甘露糖苷海关

[ 海关编码 ]: 2932999099

[ 中文概述 ]:
2932999099. 其他仅含氧杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-硝基苯基-α-D-吡喃甘露糖苷文献

Synthesis of glycopeptide dendrimers, dimerization and affinity for Concanavalin A.

Bioorg. Med. Chem. 19 , 2879-87, (2011)

We described herein the synthesis of second generation glycopeptide dendrimers G2a-g presenting variable amino acids placed internally into the multivalent scaffold. The effect of such structural modu...

ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug.

Haematologica 94 , 1528-36, (2009)

Inhibition of BCR-ABL tyrosine kinase activity has evolved as a mainstay of therapy for patients with chronic myeloid leukemia. However, a fraction of leukemic cells persists under targeted therapy an...

Mechanistic insights into a Ca2+-dependent family of alpha-mannosidases in a human gut symbiont.

Nat. Chem. Biol. 6 , 125-32, (2010)

Colonic bacteria, exemplified by Bacteroides thetaiotaomicron, play a key role in maintaining human health by harnessing large families of glycoside hydrolases (GHs) to exploit dietary polysaccharides...

更多文献